PGR and breast cancer: Among these molecular subtypes, basal-like breast cancer has a more aggressive clinical course than other subtypes and is commonly known as triple-negative breast cancer (TNBC), which is defined clinically as lacking estrogen receptor (ER) and progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2).